BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24373763)

  • 21. The American Brachytherapy Society perspective on intravascular brachytherapy.
    Nag S; Cole PE; Crocker I; Jani SK; Kishnasastry KV; Massullo V; Nath R; Nori D; Parikh S; Rubin P; Speiser B; Teirstein PS; Tripuraneni P; Waksman R; Williamson JF
    Cardiovasc Radiat Med; 1999; 1(1):8-19. PubMed ID: 11272360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy.
    Lee LJ; Das IJ; Higgins SA; Jhingran A; Small W; Thomadsen B; Viswanathan AN; Wolfson A; Eifel P;
    Brachytherapy; 2012; 11(1):53-7. PubMed ID: 22265438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression patterns of choroidal melanoma: After palladium-103 (
    Maheshwari A; Finger PT
    Eur J Ophthalmol; 2018 Nov; 28(6):722-730. PubMed ID: 29788760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
    Finger PT; Chin KJ
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):137-42. PubMed ID: 20395070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy.
    Davis BJ; Horwitz EM; Lee WR; Crook JM; Stock RG; Merrick GS; Butler WM; Grimm PD; Stone NN; Potters L; Zietman AL; Zelefsky MJ;
    Brachytherapy; 2012; 11(1):6-19. PubMed ID: 22265434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation therapy for uveal melanomas involving the ciliary body.
    Char DH
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 2)():252-6. PubMed ID: 3467500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current therapy aspects of intraocular tumors].
    Schüler AO; Bornfeld N
    Ophthalmologe; 2000 Mar; 97(3):207-22. PubMed ID: 10789180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
    Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
    Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of ciliary body melanoma with iodine-125 plaque brachytherapy.
    Krema H; Simpson ER; Pavlin CJ; Payne D; Vasquez LM; McGowan H
    Can J Ophthalmol; 2009 Aug; 44(4):395-400. PubMed ID: 19606159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plaque radiotherapy in the management of retinoblastoma.
    Kiratli H; Bilgiç S; Atahan IL
    Turk J Pediatr; 1998; 40(3):393-7. PubMed ID: 9763903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
    Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined localized current field hyperthermia and irradiation for intraocular tumors.
    Liggett PE; Ma C; Astrahan M; Pince KJ; Green R; McDonnell J; Petrovich Z
    Ophthalmology; 1991 Dec; 98(12):1830-5; discussion 1836. PubMed ID: 1775318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
    Finger PT; Berson A; Szechter A
    Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiotherapy is eye, sight, and life saving.
    Susman E
    Lancet Oncol; 2006 Jun; 7(6):458. PubMed ID: 16767834
    [No Abstract]   [Full Text] [Related]  

  • 37. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
    Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
    Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plaque brachytherapy for uveal melanoma: a vision prognostication model.
    Khan N; Khan MK; Bena J; Macklis R; Singh AD
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e285-90. PubMed ID: 22658514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI-based treatment planning and dose delivery verification for intraocular melanoma brachytherapy.
    Zoberi JE; Garcia-Ramirez J; Hedrick S; Rodriguez V; Bertelsman CG; Mackey S; Hu Y; Gach HM; Rao PK; Grigsby PW
    Brachytherapy; 2018; 17(1):31-39. PubMed ID: 28818442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.